Travel Medicine Update

Icahn School of Medicine at Mount Sinai

D. Caplivski

Project 2025 vs. the Public's Health Part II: The FDA

MicrobeTV

P. Offit, V. Racaniello

Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

MicrobeTV

D. Griffin, V. Racaniello

Nirsevimab for RSV: A Breakthrough Product for Babies

MicrobeTV

P. Offit, V. Racaniello

Hydrocortisone Reduces Mortality by 48% in Severe Community-Acquired…

MedCram

R. Seheult

IDWeek 2024 Insights: To Mask or Not to Mask - Approaches to Source …

IDWeek 2024 Insights

E. Landon

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

Project 2025 vs. the Public's Health Part III: The NIH

MicrobeTV

P. Offit, V. Racaniello

CHEST 2024 Insights: Vaccination Challenges and Strategies for Viral…

CHEST Annual Meeting Insights

A. Kapoor

What's New with COVID in 2024?

Michigan Medicine

L. Washer

ACAAI 2024 Insights: Secondary Immunodeficiency - Management Strateg…

ACAAI 2024 Insights

S. Mustafa

Newly Licensed Respiratory Syncytial Virus Vaccines for Adults: What…

MicrobeTV

P. Offit, V. Racaniello

IDSA Guidelines for Using Anti-SARS-CoV-2 Monoclonal Antibody Therap…

MicrobeTV

D. Griffin, V. Racaniello

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

MicrobeTV

D. Griffin, V. Racaniello

Vaccines for Adults: COVID, RSV, Influenza and More

Michigan Medicine

L. Washer

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

Mpox Circulation and New Vaccine Approval, Largest Outbreak of Whoop…

MicrobeTV

D. Griffin, V. Racaniello

Risk of Staphylococcus aureus Bacteremia Before and After Solid Orga…

Kengo Inagaki

IDWeek 2024 Insights: COVID-19 in Children - Navigating the Current …

IDWeek 2024 Insights

I. Anosike